PRALATREXATE
UNII A8Q8I19Q20

Substance Identification & Data

This profile provides standardized clinical and technical data for Pralatrexate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A8Q8I19Q20.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 146464-95-1 and the RxNorm Concept ID (RxCUI) 662019. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A8Q8I19Q20

CAS Registry Number

146464-95-1

RxNorm Concept ID

662019

Detailed Substance Profile

Preferred Name

PRALATREXATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

A8Q8I19Q20

The specific atomic composition represented as a molecular structure string.

InChIKey

C23H23N7O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OGSBUKJUDHAQEA-WMCAAGNKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C2250

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

148121

Unique identification number in the NCBI database of chemical substances.

INN ID

8560

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

QQ-31

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C#CCC(Cc1cnc2c(c(N)nc(N)n2)n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pralatrexate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.